Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Mr. Kyle PilkingtonChief Legal Officer | -25,00k | 30,01k | Automatic Disposition | 1,20 | 289,90k | -7,94% |
| 2026-04-14 | Ms. Jing Liu NealisInsider | -36,15k | 39,76k | Sale to Issuer | 1,10 | 1,47M | -2,40% |
| 2026-04-14 | Dr. Qichao HuFounder, Chairman & CEO | -133,30k | 146,63k | Sale to Issuer | 1,10 | 1,95M | -6,39% |
| 2026-04-14 | Mr. Kyle PilkingtonChief Legal Officer | -25,19k | 27,70k | Sale to Issuer | 1,10 | 314,90k | -7,41% |
| 2026-04-14 | Dr. Hong GanChief Science Officer | -32,14k | 35,35k | Sale to Issuer | 1,10 | 557,00k | -5,46% |
| 2026-03-27 | Ms. Jing Liu NealisInsider | -163,97k | 161,89k | Sale to Issuer | 0,99 | 1,44M | -10,25% |
| 2026-03-27 | Mr. Kyle PilkingtonChief Legal Officer | -60,45k | 59,68k | Sale to Issuer | 0,99 | 284,30k | -17,54% |
| 2026-03-27 | Dr. Kang XuCTO | -39,59k | 39,09k | Sale to Issuer | 0,99 | 263,74k | -13,05% |
| 2026-03-27 | Dr. Hong GanChief Science Officer | -74,68k | 73,73k | Sale to Issuer | 0,99 | 519,40k | -12,57% |
| 2026-03-27 | Dr. Qichao HuFounder, Chairman & CEO | -310,45k | 306,50k | Sale to Issuer | 0,99 | 1,81M | -14,67% |
| 2026-03-09 | Mr. Kyle PilkingtonChief Legal Officer | -25,00k | 30,00k | Automatic Disposition | 1,20 | 211,42k | -10,57% |
| 2026-02-09 | Mr. Kyle PilkingtonChief Legal Officer | -56,07k | 111,59k | Sale to Issuer | 1,99 | 236,42k | -19,17% |
| 2026-02-09 | Dr. Hong GanChief Science Officer | -63,29k | 125,95k | Sale to Issuer | 1,99 | 427,42k | -12,90% |
| 2026-02-06 | Dr. Kang XuCTO | -35,06k | 65,92k | Sale to Issuer | 1,88 | 220,00k | -13,75% |
| 2026-02-09 | Dr. Qichao HuFounder, Chairman & CEO | -267,93k | 533,19k | Sale to Issuer | 1,99 | 1,42M | -15,90% |
| 2026-02-09 | Ms. Jing Liu NealisInsider | -110,23k | 219,36k | Sale to Issuer | 1,99 | 1,28M | -7,91% |
| 2026-01-22 | Dr. Hong GanChief Science Officer | -250,00k | 584,71k | Derivative Exercise and Sale | 0,16 - 2,50 | 401,06k | - |
| 2025-12-15 | Dr. Hong GanChief Science Officer | -100,00k | 182,82k | Derivative Exercise and Sale | 0,15 - 1,98 | 401,06k | - |
| 2025-11-17 | Dr. Hong GanChief Science Officer | -150,00k | 262,73k | Derivative Exercise and Sale | 0,15 - 1,90 | 401,06k | - |
| 2025-09-03 | Dr. Kang XuCTO | -39,24k | 42,77k | Sale to Issuer | 1,09 | 184,44k | -17,54% |
| 2025-08-18 | Ms. Jing Liu NealisInsider | -15,69k | 16,95k | Sale to Issuer | 1,08 | 1,19M | -1,30% |
| 2025-08-08 | Mr. Kyle PilkingtonChief Legal Officer | -5,45k | 6,16k | Sale to Issuer | 1,13 | 179,50k | -2,95% |
| 2025-07-16 | Ms. Jing Liu NealisInsider | -15,69k | 15,44k | Sale to Issuer | 0,98 | 1,21M | -1,29% |
| 2025-06-16 | Ms. Jing Liu NealisInsider | -15,69k | 15,04k | Sale to Issuer | 0,96 | 1,22M | -1,27% |
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
